SEC Form 4 · accession 0001104659-26-093580
Latigo Biotherapeutics, Inc. · LTGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Foresite Capital Fund V, L.P.
10% Owner
Foresite Capital Management V, LLC
10% Owner
Foresite Capital Fund VI LP
10% Owner
Foresite Capital Management VI LLC
10% Owner
Period of report
Aug 10, 2026
Accepted (ET)
Aug 10, 2026 · 8:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002056611
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 10, 2026 | C | 3,117,664 | $0.00 | A | 3,117,664 | I | See Footnote |
| Common StockF2 | Aug 10, 2026 | C | 445,320 | $0.00 | A | 3,562,984 | I | See Footnote |
| Common StockF3 | Aug 10, 2026 | C | 1,125,823 | $0.00 | A | 1,125,823 | I | See Footnote |
| Common StockF3 | Aug 10, 2026 | C | 742,201 | $0.00 | A | 1,868,024 | I | See Footnote |
| Common StockF3 | Aug 10, 2026 | P | 140,000 | $18.00 | A | 2,008,024 | I | See Footnote |
| Common StockF5,F3 | Aug 10, 2026 | C | 195,776 | — | A | 2,203,800 | I | See Footnote |
| Common StockF4 | Aug 10, 2026 | C | 3,117,664 | $0.00 | A | 3,117,664 | I | See Footnote |
| Common StockF4 | Aug 10, 2026 | C | 296,880 | $0.00 | A | 3,414,544 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A-2 Convertible Preferred StockF2,F1 | — | Aug 10, 2026 | C | 3,117,664 | D | — | — | Common Stock | 3,117,664 | 0 | I |
| Series B Convertible Preferred StockF2,F1 | — | Aug 10, 2026 | C | 445,320 | D | — | — | Common Stock | 445,320 | 0 | I |
| Series A-2 Convertible Preferred StockF3,F1 | — | Aug 10, 2026 | C | 1,125,823 | D | — | — | Common Stock | 1,125,823 | 0 | I |
| Series B Convertible Preferred StockF3,F1 | — | Aug 10, 2026 | C | 742,201 | D | — | — | Common Stock | 742,201 | 0 | I |
| Series A-2 Convertible Preferred StockF4,F1 | — | Aug 10, 2026 | C | 3,117,664 | D | — | — | Common Stock | 3,117,664 | 0 | I |
| Series B Convertible Preferred StockF4,F1 | — | Aug 10, 2026 | C | 296,880 | D | — | — | Common Stock | 296,880 | 0 | I |
| Convertible Promissory NoteF5,F3 | — | Aug 10, 2026 | C | 195,776 | D | — | — | Common Stock | 195,776 | 0 | I |
Explanation of responses
- F1Each share of the Issuer's preferred stock converted automatically into 1 share of common stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The preferred stock had no expiration date.
- F2The securities are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. James B. Tananbaum (Tananbaum) is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over the securities held by Fund V. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F3The securities are held of record by Foresite Capital Fund VI LP ("Fund VI"). Foresite Capital Management VI, LLC ("FCM VI") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Tananbaum is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F4The securities are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over the shares held by Opportunity Fund V. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over the securities held by Opportunity Fund V. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F5Reflects a convertible note that is convertible into shares of Common Stock of the Issuer. The convertible note has a maturity date of June 17, 2027. The principal amount of the convertible note together with any accrued but unpaid interest automatically converted into shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering at a conversion price equal to the initial public offering price of the Issuer's common stock.